Agilent Technologies (A) Liabilities from Discontinued Operations (2014)
Agilent Technologies' (A) quarterly Liabilities from Discontinued Operations came in at $2.1 billion in Q4 2014.
Powered by 
Analysis
Agilent Technologies (A) Liabilities from Discontinued Operations (2014) Analysis & Trends
Agilent Technologies (A) has reported Liabilities from Discontinued Operations for 1 consecutive years, with $2.1 billion the latest figure, recorded in Q4 2014.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $2.1 billion in Q4 2014; TTM through Oct 2014 was $2.1 billion, a N/A change from a year earlier, with the FY2014 full-year figure at $2.1 billion, changed N/A from the prior year.
- Liabilities from Discontinued Operations was $2.1 billion for Q4 2014 at Agilent Technologies.
- Over five years, Liabilities from Discontinued Operations peaked at $2.1 billion in Q4 2014 and troughed at $2.1 billion in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |